DLX4 and chronic myelogenous leukemia, BCR-ABL1 positive: The AUC value for BP1 and DLX7 were 0.624 (95% CI 0.520–0.727, P = 0.034, Fig. 1d) and 0.699 (95% CI 0.605–0.793, P = 0.001, Fig. 1e), suggesting that they may serve as potential biomarkers for distinguishing CML patients from controls.